“borderline significant”

Similar to the L6 diet, the H3-L6 diet also increased PGF2a concentration by 21% compared to baseline, but this increase was borderline significant ( p = 0.05).

7 ): Continuous aerobic exercise (5 studies, n =142) showed a borderline significant reduction (pooled SMD = -0.35, 95% CI: -0.69 to-0.01; Z = 1.99, P = 0.05) with negligible heterogeneity (I2= 0%).

BUN was borderline significant (β = 3.5, p = 0.05).

Conversely, borderline significant differences were observed in WBC count on day3, day5, and day7 after CC ( P < 0.05) except for day1.

Results were considered statistically significant at P < 0.05, with P values for borderline significant results approaching P = 0.05 also reported.

Excluding the patients that had no measurable CTCs, there was a borderline significant difference between median CTC count in the patients that did and that did not have HER2-positive CTCs ( p = 0.05, Mann–Whitney U test).

Otherwise, we examined univariate analysis results. To eliminate the impact of the borderline significant results, we considered P≤0.05 as significant (not P=0.051).

There were no significant differences in demographic variables and cognitive assessment scores between the groups, except for a borderline significant difference ( P = 0.05) in the MOCA score (Supplementary Table 1 ).

A borderline significant difference was found in blast percentage ( p = 0.05), with more patients in the WT1 high group having blast counts ≥80%.

In the Ps of UK Biobank as exposure (nSNP = 7), the IVW method manifested a borderline significant positive link ( β = 0.024, 95%CI = 1.02 (1.00, 1.05); p = 0.050).

The main result for the primary outcome is borderline significant (RR=0.85 [0.72-1.00], p=0.05), it is difficult to interpret this result.

The USG spot samples (morning: 1.018 [1.008—1.028] and afternoon: 1.011 [1.000–1.026]) were borderline significant with p = 0.05).

One test assessing executive functioning, Category Switching, was borderline significant, p = 0.050.

A borderline significant association remained after controlling for differences in age category, sex, and site location (odds ratio [OR]: 1.70, 95% CI [1.00, 2.88], p = 0.05).

Age showed a borderline significant link with mortality (p=0.05), suggesting a slight risk increase with age.

Furthermore, when analyzed as a continuous variable, higher CRP levels showed a borderline significant association with an increased risk of mortality (aOR = 1.038, 95% CI (1.000, 1.077), p = 0.050), but not with any of the other outcomes ( Table 3 ).

For LDL cholesterol, Olpasiran showed a modest reduction (MD: -10.22 mg/dL, 95% CI: [-33.50; 13.06], p = 0.39), while Zerlasiran achieved a more substantial but borderline significant effect (MD: -23.94 mg/dL, 95% CI: [-48.11; -0.22], p = 0.05).

Subgroup Analyses Based on I2 and the p-value for heterogeneity, the progression of LGD to HGD or EAC showed borderline significant substantial heterogeneity (I2 = 66%; p = 0.05), LGD to HGD showed statistically insignificant low heterogeneity (I2 = 15%; p = 0.31), and LGD to EAC showed statistically insignificant moderate-to-substantial heterogeneity (I2 = 60%; p = 0.11).

In the full model, COVID-19 was borderline significant ( p = 0.05), while age was highly significant ( p < 0.01).

On average NSW-S missed 11 prompts (32%) out of the 35 sent, with the difference between all the three groups being borderline significant ( p = 0.05).

However, there was a borderline significant difference in gender distribution between the clusters ( χ 2 1 =3.84; P =.05).

Still, there was a borderline significant difference between the groups vis-à-vis educational attainment ( P =0.05).

In the patient group, response times to addition sums that bridged a decade (M = 4431.18, SD = 4197.4) showed a borderline significant difference from those addition sums that did not bridge a decade (M = 3698.98, SD = 3765); standardized test statistic = −1.96, n = 9, p = 0.05.

Treatment protocols revealed a borderline significant difference ( p = 0.05).

Home O 2 use was borderline significant after adjustment for these additional variables (OR: 1.74; 95% CI: 0.99 - 3.04, P = 0.050.) Figure 1 demonstrates a Kaplan-Meir survival analysis showing a significant increase in all cause mortality in the home O 2 cohort with an overall mean (95% CI) survival time of 6.2 (5.9 - 6.5) years (P < 0.001).